ZBIO – zenas biopharma, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ZBIO

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/12

07:23 am

zbio

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]

Low Report

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates [Yahoo! Finance]

Report

11/12

07:10 am

zbio

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Low Report

Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Report

11/12

07:05 am

zbio

Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

Low Report

Zenas BioPharma Completes Targeted Enrollment of the Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD)

Report

11/7

07:05 am

zbio

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

Low Report

Zenas BioPharma to Participate in Upcoming Healthcare Investor Conferences

Report

10/22

06:28 pm

zbio

Zenas Bio: Recent IPO With Late-Stage Candidate [Seeking Alpha]

Medium Report

Zenas Bio: Recent IPO With Late-Stage Candidate [Seeking Alpha]

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.